Kolexia
Malfuson Jean-Valere Hématologie
Malfuson Jean-Valere
Hématologie
Hopital Instruction des Armees Percy
Clamart, France
130 Activités
2 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Myélome multiple Lymphomes Maladie du greffon contre l'hôte Maladie de Hodgkin Syndromes myélodysplasiques Anémie

Collaborateurs

Voir plus
Konopacki Potet Johanna
Konopacki Potet Johanna
Hopital Instruction des Armees Percy, Clamart, France
Thomas Xavier
Thomas Xavier
Hôpital Lyon Sud, Pierre-Bénite, France
Dombret Herve
Dombret Herve
Hôpital Saint-Louis, Paris, France
Raffoux Emmanuel
Raffoux Emmanuel
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
Janssen
7 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
6 collaboration(s)
Dernière en 2021
Novartis
4 collaboration(s)
Dernière en 2023
Abbvie
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.
Annals of hematology   06 mars 2024
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Annals of hematology   26 janvier 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
Journal of hematology & oncology   07 janvier 2024
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
British journal of haematology   02 octobre 2023
Treatment with anti CD19 CAR-T cells is safe and effective in patients with relapsed refractory large B-cell lymphoma with active central nervous system involvement
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia.
Leukemia research reports   16 mars 2023
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Haematologica   09 mars 2023
A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma: A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral Ixazomib (MLN9708) Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
Essai Clinique (Takeda Pharmaceutical)   07 février 2023
FIRE: A Retro-Prospective Observational Study of Ibrutinib Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice
Essai Clinique (Janssen)   05 octobre 2022
IFM2014-02: IFM 2014-02 Study: A Randomized Phase III Study of Bortezomib-Melphalan 200 Conditioning Regimen Versus Melphalan 200 for Frontline Transplant Eligible Patients With Multiple Myeloma
Essai Clinique (Janssen)   17 mai 2022